News for Chimerix, Inc. (CMRX)

PR NewswireDUBLIN, May 6, 2025 ”“ Total revenues of $898 million in 1Q25 ”“”“ Xywav® and Epidiolex® revenues grew 9% and 10% year-over-year, respectiv

PR NewswireDUBLIN, April 23, 2025 Statistically significant and clinically meaningful progression-free survival (PFS) and overall survival (OS) data for Ze

We recently published a list of 11 Best Performing NASDAQ Stocks So Far in 2025. In this article, we are going to take a look at where Chimerix Inc.

Net Loss: Reported a net loss of $23.0 million for Q4 2024, translating to $0.25 per share, slightly better than the estimated EPS of -$0.26.Revenue: Achieved

New Drug Application (NDA) for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma Under Review with Prescription Drug User Fee Act (PDUFA) Ac

PR NewswireNEW YORK, March 17, 2025 NEW YORK, March 17, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following

NEW YORK, March 12, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations

PR NewswireNEW YORK, March 11, 2025 NEW YORK, March 11, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following

We recently compiled a list of the 10 Micro-, Small-Cap Firms Were Last Week's Top Performers. In this article, we are going to take a look at where Chimerix, Inc.

NEW YORK, March 08, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations

DURHAM, N.C., March 07, 2025 (GLOBE NEWSWIRE) -- Chimerix (CMRX), today announced that on March 2, 2025, the Compensation Committee of Chimerix's Board of Dir

**media[560522]**

NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Chimerix, Inc. ( CMRX) to Jaz

Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals are included in this Analyst Blog.

North Carolina-based Chimerix, Inc. (CMRX) is up over 69 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Chimerix, Inc. (NASDAQ: CMRX) to Jazz Pharmaceuticals plc for $8.55 per sha

Transaction Overview On December 31, 2024, Rosalind Advisors, Inc. (Trades, Portfolio) made a strategic move by acquiring an additional 9,536,647 shares in Biof

**media[527622]**

**media[523712]**